Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-217082
Filing Date
2026-05-11
Accepted
2026-05-11 17:04:17
Documents
85
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q agen-20260331.htm   iXBRL 10-Q 2303463
2 EX-31.1 agen-ex31_1.htm EX-31.1 17138
3 EX-32.1 agen-ex32_1.htm EX-32.1 8843
  Complete submission text file 0001193125-26-217082.txt   10684710

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT agen-20260331.xsd EX-101.SCH 1696017
89 EXTRACTED XBRL INSTANCE DOCUMENT agen-20260331_htm.xml XML 1913992
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

EIN.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 26964320
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)